Amylyx Pharmaceuticals Inc.

03/17/2025 | Press release | Archived content

WATERTOWN, Mass. , March 17, 2025 (GLOBE NEWSWIRE) EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing therapeutics to help[...]

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.
Amylyx Pharmaceuticals Inc. published this content on March 17, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on April 03, 2025 at 00:24 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]